Accessing hepatitis C direct acting antivirals among people living with hepatitis C: a qualitative study
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource, 1 online resource.
- Sprache
-
Englisch
- Erschienen in
-
Accessing hepatitis C direct acting antivirals among people living with hepatitis C: a qualitative study ; volume:22 ; number:1 ; day:6 ; month:6 ; year:2023 ; pages:1-13 ; date:12.2023
International journal for equity in health ; 22, Heft 1 (6.6.2023), 1-13, 12.2023
- Urheber
-
Antoniou, Tony
Pritlove, Cheryl
Shearer, Dana
Tadrous, Mina
Shah, Hemant
Gomes, Tara
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12939-023-01924-4
- URN
-
urn:nbn:de:101:1-2023091516132064876033
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:51 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Antoniou, Tony
- Pritlove, Cheryl
- Shearer, Dana
- Tadrous, Mina
- Shah, Hemant
- Gomes, Tara
- SpringerLink (Online service)
Ähnliche Objekte (12)
Correction: Accessing hepatitis C direct acting antivirals among people living with hepatitis C: a qualitative study
Psychiatric treatment considerations with direct acting antivirals in hepatitis C
Economic Evaluation of Direct-Acting Antivirals for Hepatitis C in Norway
Hepatitis C clearance by direct-acting antivirals impacts glucose and lipid homeostasis
Managing HIV/hepatitis C co-infection in the era of direct acting antivirals
Impact of direct-acting antivirals on neuropsychiatric and neurocognitive dysfunction in chronic hepatitis C patients
Hepatitis C in the era of direct-acting antivirals: real-world costs of untreated chronic hepatitis C; a cross-sectional study
Plant-derived antivirals against hepatitis c virus infection
Effect of direct-acting antivirals on elastographic measures in patients with chronic hepatitis C virus infection
Safety and efficacy of direct-acting antivirals for chronic hepatitis C in patients with chronic kidney disease
Continuum of hepatitis C care cascade in prison and following release in the direct-acting antivirals era
Reported adverse events related to use of hepatitis C virus direct-acting antivirals with opioids: 2017–2021
Correction: Accessing hepatitis C direct acting antivirals among people living with hepatitis C: a qualitative study
Psychiatric treatment considerations with direct acting antivirals in hepatitis C
Economic Evaluation of Direct-Acting Antivirals for Hepatitis C in Norway
Hepatitis C clearance by direct-acting antivirals impacts glucose and lipid homeostasis
Managing HIV/hepatitis C co-infection in the era of direct acting antivirals
Impact of direct-acting antivirals on neuropsychiatric and neurocognitive dysfunction in chronic hepatitis C patients
Hepatitis C in the era of direct-acting antivirals: real-world costs of untreated chronic hepatitis C; a cross-sectional study
Plant-derived antivirals against hepatitis c virus infection
Effect of direct-acting antivirals on elastographic measures in patients with chronic hepatitis C virus infection
Safety and efficacy of direct-acting antivirals for chronic hepatitis C in patients with chronic kidney disease
Continuum of hepatitis C care cascade in prison and following release in the direct-acting antivirals era
Reported adverse events related to use of hepatitis C virus direct-acting antivirals with opioids: 2017–2021
Correction: Accessing hepatitis C direct acting antivirals among people living with hepatitis C: a qualitative study
Psychiatric treatment considerations with direct acting antivirals in hepatitis C
Economic Evaluation of Direct-Acting Antivirals for Hepatitis C in Norway
Hepatitis C clearance by direct-acting antivirals impacts glucose and lipid homeostasis
Managing HIV/hepatitis C co-infection in the era of direct acting antivirals
Impact of direct-acting antivirals on neuropsychiatric and neurocognitive dysfunction in chronic hepatitis C patients
Hepatitis C in the era of direct-acting antivirals: real-world costs of untreated chronic hepatitis C; a cross-sectional study
Plant-derived antivirals against hepatitis c virus infection
Effect of direct-acting antivirals on elastographic measures in patients with chronic hepatitis C virus infection
Safety and efficacy of direct-acting antivirals for chronic hepatitis C in patients with chronic kidney disease
Continuum of hepatitis C care cascade in prison and following release in the direct-acting antivirals era